Omnicell, Inc. Provides Earnings Guidance for the First Quarter and Full Fiscal Year 2024
February 08, 2024 at 01:04 pm
Share
Omnicell, Inc. provided earnings guidance for the first quarter and full fiscal year 2024. For the quarter, the company expects Total Revenues in the range of $232 million - $242 million.
For the year, the company expects Total Revenues in the range of $1.045 billion - $1.120 billion.
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Companyâs XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.